Europe — EMA
Morfin Sad (Morphine Hydrochloride Trihydrate)
GNH USA supplies Morfin Sad (Morphine), an opioid analgesic for moderate to severe pain management. Request a quote for global supply.
Request sourcing
What is Morphine Hydrochloride Trihydrate?
Morphine, the active ingredient in Morfin Sad, is an opioid analgesic presented as an oral formulation for oral use. It treats moderate to severe pain in adult patients requiring strong analgesia. GNH USA supplies Morfin Sad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Morphine Hydrochloride Trihydrate used for?
Morphine is an opioid analgesic used to manage pain through central nervous system pathways.
Acute severe pain: provides rapid relief of intense pain episodes. Chronic cancer pain: helps control persistent pain associated with malignant disease. Post‑operative pain: reduces pain after surgical procedures. Palliative‑care pain: alleviates distressing pain in end‑of‑life settings.
What are the side effects of Morphine Hydrochloride Trihydrate?
Morphine may cause a range of adverse reactions that vary in frequency and severity.
Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness
Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic reaction
What precautions apply to Morphine Hydrochloride Trihydrate?
When prescribing or dispensing Morphine, careful assessment and monitoring are essential.
Assess pain level before initiating therapy: ensure opioid indication is appropriate. Monitor respiratory function: watch for signs of hypoventilation. Evaluate for opioid dependence risk: consider patient history. Adjust dose in renal or hepatic impairment: use lower starting doses. Avoid concomitant CNS depressants when possible: reduce additive sedation. Store at room temperature: keep in original packaging, protect from moisture and light.
What does Morphine Hydrochloride Trihydrate interact with?
Morphine interacts with several drug classes; awareness of interaction severity guides clinical decisions.
Major Interactions (Avoid): - Other opioids: additive respiratory depression. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Central nervous system depressants (e.g., benzodiazepines): profound sedation.
Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase morphine levels. - CYP2D6 inhibitors (e.g., fluoxetine): can alter metabolism. - Diuretics: may enhance hypotensive effects.



